|
|
A vaccine against cancer may be available within three years
Can be in three years to have a vaccine against cancer yet ready to show the possibility of future use based on the results of use.
Vaccine works so prompt the immune system and the destruction of tumors, this applied to 90 percent of cases of breast cancer in lab tests.
Antibodies attack intervened and surrounded the cancer cells and kill them. Conducted tests on mice, and was particularly successful on the breast and pancreatic tumors.
Developed a team of University of Georgia, where the vaccine now begin tests on human cells.
Can begin clinical trials on humans by the year 2013. Said study leader Professor Gert Jan Boots, "that the vaccine raises a very strong immune response, and activates all three components of the immune system to reduce the size of the tumor."
The Professor Gert Jan Boots saying that "the vaccine raises a very strong immune response, and activates all three components of the immune system to reduce the size of the tumor."
He said co-author Professor Sandra Jndler, from the Mayo Clinic in Arizona, "This is the first time that the development of a cancer vaccine to train the immune system of discrimination and kill cancer cells depending on different combinations of sugar in it."
British experts have welcomed the results. Dr. Balaframan Caitlin, who has performed his experiments on the penetration of breast cancer, said: "This exciting new approach could lead to treatments for breast cancer patients who have few options."
But it said it needed to conduct tests on patients.
Can be in three years to have a vaccine against cancer yet ready to show the possibility of future use based on the results of use.
Vaccine works so prompt the immune system and the destruction of tumors, this applied to 90 percent of cases of breast cancer in lab tests.
Antibodies attack intervened and surrounded the cancer cells and kill them. Conducted tests on mice, and was particularly successful on the breast and pancreatic tumors.
Developed a team of University of Georgia, where the vaccine now begin tests on human cells.
Can begin clinical trials on humans by the year 2013. Said study leader Professor Gert Jan Boots, "that the vaccine raises a very strong immune response, and activates all three components of the immune system to reduce the size of the tumor."
The Professor Gert Jan Boots saying that "the vaccine raises a very strong immune response, and activates all three components of the immune system to reduce the size of the tumor."
He said co-author Professor Sandra Jndler, from the Mayo Clinic in Arizona, "This is the first time that the development of a cancer vaccine to train the immune system of discrimination and kill cancer cells depending on different combinations of sugar in it."
British experts have welcomed the results. Dr. Balaframan Caitlin, who has performed his experiments on the penetration of breast cancer, said: "This exciting new approach could lead to treatments for breast cancer patients who have few options."
But it said it needed to conduct tests on patients.
0 Comments:
Post a Comment